Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GW406381 in dental pain after third molar extraction
NCT00114049Phase 3Completed
- Sponsor
- GSK
- Start
- Dec 2004
- Primary completion
- Apr 2005
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of GW406381 in odontalgia (6 arms), sponsored by GSK. Primary endpoint: Pain Relief Intensity Difference. Started Dec 2004; status: completed.
02
Drugs
GW406381
03
Conditions
odontalgia
Beyond the preview
Go deeper on NCT00114049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00114049.